Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer

18Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: To evaluate the clinical efficacy and safety of mitomycin C in the local control of malignant pericardial effusion, we carried out a trial of pericardial drainage with local instillation of mitomycin C in eight patients who suffered from cardiac tamponade or symptomatic large pericardial effusion caused by advanced non-small cell lung cancer. Methods: After complete removal of the pericardial effusion by an ultrasound-guided inserted catheter, 2 mg of mitomycin C was instilled into the pericardial space via the catheter. Results: The drainage catheter was successfully removed in all patients. The duration of pericardial drainage ranged from 7 to 14 days (median 10.5 days). Six of the eight patients achieved a complete remission of pericardial effusions without any adverse effects. Conclusion: Intrapericardial instillation of 2 mg of mitomycin C was feasible and demonstrated a promising response against malignant pericardial effusion resulting from non-small cell lung cancer. © 2005 Foundation for Promotion of Cancer Research.

Cite

CITATION STYLE

APA

Kaira, K., Takise, A., Kobayashi, G., Utsugi, M., Horie, T., Mori, T., … Mori, M. (2005). Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer. Japanese Journal of Clinical Oncology, 35(2), 57–60. https://doi.org/10.1093/jjco/hyi019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free